share_log

EXCLUSIVE: NeuroSense Therapeutics Tells Benzinga Co. Reports That It Is Currently In Advanced Discussions With Several Multi-Billion-Dollar Pharmaceutical Companies Regarding A Potential Strategic Partnership For The Development And Commercialization...

Benzinga ·  Aug 28 19:02

EXCLUSIVE: NeuroSense Therapeutics Tells Benzinga Co. Reports That It Is Currently In Advanced Discussions With Several Multi-Billion-Dollar Pharmaceutical Companies Regarding A Potential Strategic Partnership For The Development And Commercialization Of Its Lead Drug Candidate, PrimeC, For The Treatment Of Amyotrophic Lateral Sclerosis (ALS)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment